DFN-11

DRUG2 trials

Sponsors

Dr. Reddy's Laboratories Limited

Conditions

Episodic MigraineRapidly Escalating Migraine

Phase 2

Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine

CompletedNCT02571049

Dr. Reddy's Laboratories LimitedRapidly Escalating Migraine

Start: 2015-09-30End: 2016-05-31Updated: 2019-02-26

Phase 3

DFN-11 Injection in Episodic Migraine With or Without Aura

CompletedNCT02569853

Dr. Reddy's Laboratories LimitedEpisodic Migraine

Start: 2015-09-21End: 2018-02-26Updated: 2018-07-26

Related Papers

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study

The Journal of Headache and Pain2018-08-1522 citations

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study.

2018-08-153 citations